2020
DOI: 10.1016/j.actbio.2020.04.046
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
56
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(63 citation statements)
references
References 31 publications
0
56
0
Order By: Relevance
“…Furthermore, photoimmune therapy, chemotherapy, and thermal therapy have been experimentally developed in a liver cancer model. Thus, the clinical application of PDT using the novel PS is promising for hepatobiliary malignancy treatment in the future [102][103][104]. Figure 3 showed our experienced cases of PD imaging in HCC patients.…”
Section: Recent Pdd Using Ala and Icg-based Nir Fluorescence Imagingmentioning
confidence: 99%
“…Furthermore, photoimmune therapy, chemotherapy, and thermal therapy have been experimentally developed in a liver cancer model. Thus, the clinical application of PDT using the novel PS is promising for hepatobiliary malignancy treatment in the future [102][103][104]. Figure 3 showed our experienced cases of PD imaging in HCC patients.…”
Section: Recent Pdd Using Ala and Icg-based Nir Fluorescence Imagingmentioning
confidence: 99%
“…The anti-VEGFR antibody can kill tumor cells by inhibiting angiogenesis via PI3K/AKT pathways. The nanoparticles avoid the immune system through immune escape, accurately locate HCC cells through liver cancer targeting, and kill tumor cells through PTT and kinase inhibition ( 66 , 67 ).…”
Section: Pttmentioning
confidence: 99%
“… 18–20 To overcome the functional limitations of using single-cell membranes to enhance the functionality of nanomaterials, researchers have developed specialized platforms to prepare hybrid membranes for camouflaging NPs by fusing membranes from different types of cells such as red blood cells and cancer cells, 21 platelets and red blood cells, 22 and cancer cells and macrophages. 23 However, to the best of our knowledge, membranes from platelets and glioma cells have not been used to fabricate hybrid membranes. In this study, we developed tumor-targeting NPs with excellent targeting and immune escape capabilities by fabricating platelet and glioma hybrid membranes to enhance the efficacy of cancer therapy.…”
Section: Introductionmentioning
confidence: 99%